申请人:Sankyo Company, Limited
公开号:US05104888A1
公开(公告)日:1992-04-14
Compounds of formula (I): ##STR1## (in which R.sup.1 -R.sup.7 are hydrogen or various organic groups, n is 1-10, Ar is an aromatic group, U is CH.sub.2 or a carbon atom doubly bonded to either one of its adjacent carbons, and W is >CH.sub.2, >C.dbd.O, >CHOH, >C.dbd.NOH or various derivatives thereof) have the ability to lower the levels of blood lipid peroxides and blood sugars and to inhibit the activity of aldose reductase; they may be used therapeutically for these purposes.
公式(I)的化合物:##STR1##(其中R.sup.1 -R.sup.7是氢或各种有机基团,n是1-10,Ar是芳香族基团,U是CH.sub.2或一个碳原子与任一相邻的碳原子双键连接,W是>CH.sub.2,>C.dbd.O,>CHOH,>C.dbd.NOH或其各种衍生物)具有降低血脂过氧化物和血糖水平以及抑制醛糖还原酶活性的能力;它们可以用于这些目的的治疗。